Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

“Charting the Translational Pathway: ISSCR Best Practices for the Development of PSC-Derived Therapies,” offers insights into the comprehensive, globally informed guide to navigating the complex ...

Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

A Japanese health ministry panel has endorsed two products using iPS cells, paving the way for the world's first practical ...

The earliest they are likely to become available is around summer, after drug pricing has been finalized. These products will be covered by the public health insurance system. The out-of-pocket burden ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial. It's a ...

Researchers say that a new type of stem cell therapy could help treat people with Parkinson’s disease, slowing down tremors and other motor impacts that greatly affect daily life. The treatment works ...

Add Yahoo as a preferred source to see more of our stories on Google. Kim and Khloé Kardashian had stem cell therapy in Mexico overseen by Dr. Adeel Khan. (Photo illustration: Yahoo News; photos: Kim ...